United States

Showing 41-50 of 345 grants

Title	Institution	Researcher	Program	Duration	Total Award Amount
Development and testing of protease-resistant CXCL12 loaded sub 100 micron polymeric microbeads to enable alloislet transplantation without systemic immune suppression in established murine models of type 1 diabetes	Massachusetts General Hospital	Mark Poznansky	Cures	01-February-2026 to 31-January-2028	$599,448.76
3D bioprinted pancreatic tissue for beta cell replacement therapy	Wake Forest University Health Sciences	Amish Asthana	Cures	01-March-2026 to 29-February-2028	$599,990.14
Subcutaneous In Vivo Engraftment and Vascularization of 3D Bioprinted Pancreatic-Like Tissue	FluidForm Bio	Adam Feinberg	Cures	23-December-2025 to 12-June-2026	$228,696.00
Project Tuyinza	The Sonia Nabeta Foundation	Vivian Nabeta	Mission	01-April-2026 to 31-March-2029	$643,550.00
Reducing Health Disparities and Improving Outcomes in Type 1 Diabetes Through a Novel Community-Focused Digital Care Model	Blue Circle Health	Leonard D’Avolio	Mission	01-January-2026 to 31-December-2028	$1,500,000.00
GNTI-122 for the treatment of recently diagnosed type 1 diabetes	GentiBio	Mark Bach	Cures	01-December-2025 to 30-November-2027	$4,000,000.00
Collaboration for Global T1D Care	Acora	Rebecca Goldman	Mission	01-December-2025 to 31-January-2027	$648,500.00
Advancing Breakthroughs in Type 1 Diabetes Research with Safe and Immune Cloaked Stem Cells	Pluristyx	Benjamin Fryer	Cures	15-November-2025 to 14-November-2027	$704,860.20
Programming Pancreatic Cell Replacement Therapeutics Using Cellgorithm Technology	Syntax Bio, Inc	Ryan Clarke	Cures	15-November-2025 to 14-November-2027	$856,250.00
Modes of action of a beta cell targeted prodrug for preventing and treating type 1 diabetes	UT Southwestern	Wen-hong Li	Cures	01-November-2025 to 31-October-2028	$990,000.00